Clinical Trials Browser

Available × INDUSTRY × Carcinoma × Clear all

NCT04146571 2022-10-20

Expanded Access to Ensartinib for Participants With ALK+ NSCLC

Carcinoma, Carcinoma, Non-Small-Cell Lung